MARKET

BIXT

BIXT

Bioxytran Inc
OTCMQB
0.178
+0.028
+18.67%
Closed 15:46 03/21 EDT
OPEN
0.155
PREV CLOSE
0.150
HIGH
0.179
LOW
0.150
VOLUME
291.76K
TURNOVER
49.27K
52 WEEK HIGH
0.206
52 WEEK LOW
0.062
MARKET CAP
15.69M
P/E (TTM)
-9.5187
1D
5D
1M
3M
1Y
5Y
1D
BIOXYTRAN SIGNS NDA WITH THE UNIVERSITY OF GEORGIA TO EVALUATE GALECTIN ANTAGONISTS FOR BIRD FLU TREATMENT IN CHICKENS
Reuters · 4d ago
Weekly Report: what happened at BIXT last week (0310-0314)?
Weekly Report · 6d ago
BIOXYTRAN: WE ARE ACTIVELY SEEKING PARTNERSHIPS
Reuters · 03/12 13:30
Bioxytran Develops a Groundbreaking Treatment to Combat Bird Flu in Egg Laying Chickens Potentially Saving Billions
Barchart · 03/12 08:30
Weekly Report: what happened at BIXT last week (0303-0307)?
Weekly Report · 03/10 11:26
Weekly Report: what happened at BIXT last week (0224-0228)?
Weekly Report · 03/03 11:25
Weekly Report: what happened at BIXT last week (0217-0221)?
Weekly Report · 02/24 11:24
Weekly Report: what happened at BIXT last week (0210-0214)?
Weekly Report · 02/17 11:22
More
About BIXT
Bioxytran, Inc. is a clinical-stage pharmaceutical company. The Company is focused on the development, manufacture, and commercialization of therapeutic drugs designed to address hypoxia in humans. The Company's lead drug candidate, code named BXT-25, is an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer with an intended application, which includes the treatment of hypoxic conditions in the brain resulting from stroke. The Company, through its subsidiary, Pharmalectin Inc., is focused on the development, manufacturing, and commercialization of therapeutic drugs designed to address viral diseases in humans. Pharmalectin Inc. has developed a method designed to reduce the viral load and modulate the immune system using a galectin inhibitor. Its lead drug candidate, named ProLectin-Rx, is a complex polysaccharide derived from pectin that binds to, and blocks the activity of galectin-1, a type of galectin.

Webull offers Bioxytran Inc stock information, including OTCMQB: BIXT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIXT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIXT stock methods without spending real money on the virtual paper trading platform.